Atlas Trials

Study on Human Bioequivalence of Triprerelin Acetate for Injection

Clinical trial NCT06683066 · RECRUITING

Trial details

NCT number
NCT06683066
Sponsor
The Affiliated Hospital of Qingdao University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer (CRPC)
Start date
2024-12-04
Primary completion
2025-09-04
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.